Person

Back to overview Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Endothelial cell protection and attenuation of innate immunity in ischemia/reperfusion injury and organ transplantation
Rieben Robert University of Berne - BE 01.05.2007 30.04.2010 Project funding (Div. I-III)

Xeno2Cure - advanced engineering and testing of organ donor pigs
Rieben Robert University of Berne - BE 01.04.2021 31.03.2025 Sinergia

New Synthetic ABO-Immunoabsorbents: in Vitro Evaluation of Effi- cacy and Biocompatibility.
Rieben Robert University of Berne - BE 04.09.1993 03.10.1993 International short research visits

Characterization of xenoantigens and -antibodies in the pig-to- human and guinea-pig/hamster-to-rat models.
Rieben Robert Institution abroad - IACH 01.03.1995 31.12.1996 Fellowships for advanced researchers

Endothelial cell protection in ischemia / reperfusion injury and acute vascular xenograft rejection.
Rieben Robert University of Berne - BE 01.04.2004 31.03.2007 Project funding (Div. I-III)

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Unravelling consequences of SARS-CoV-2 mediated inflammatory immune responses in heart and vasculature
Döring Yvonne University of Berne - BE 01.11.2020 31.10.2022 NRP 78 Covid-19

ABO-incompatibility and hyperacute xenograft rejection
Seebach Jörg Dieter University of Zurich - ZH 01.10.2000 30.09.2005 NRP 46 Implants and Transplants

Microscopy Equipment for Organ-on-Chips and Perfused Microfluidic Systems with High Speed Camera
Guenat Olivier University of Berne - BE 01.12.2014 30.11.2016 R'EQUIP

Projects as member of staff

Responsible applicant Institution of higher education Start End date Funding scheme

Antigen-specifity and subclass distribution of platelet- associated IgG - departure from distribution of serum IgG?
Nydegger Urs University of Berne - BE 01.04.1990 31.03.1993 Project funding (Div. I-III)

Projects as project partner

Responsible applicant Institution of higher education Start End date Funding scheme

Sweet control: Sialoglycans in cell-mediated anti-tumor responses
von Gunten Stephan University of Berne - BE 01.04.2019 31.03.2023 Project funding (Div. I-III)

Antibody-dependent innate immune cell functions in autoimmunity and monoclonal antibody therapies
Seebach Jörg Dieter University of Geneva - GE 01.10.2021 30.09.2025 Project funding (Div. I-III)

-